IS3N:XETRA:XETRA-iShares Core MSCI Emerging Markets IMI UCITS (EUR)

ETF | Others |

Last Closing

USD 33.252

Change

-0.01 (-0.04)%

Market Cap

USD 24.16B

Volume

0.09M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.48 (+0.95%)

USD 420.85B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.16 (+0.96%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.22 (+0.82%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.27 (+0.96%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.29 (+1.18%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.35 (+0.78%)

USD 102.32B
8R80:XETRA Amundi Index Solutions - Amund..

+1.10 (+0.77%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.53 (+1.07%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.08 (+0.08%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.16 (+0.20%)

USD 80.38B

ETFs Containing IS3N:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.66% 71% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.66% 71% C- 72% C
Trailing 12 Months  
Capital Gain 24.91% 64% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.91% 65% D 67% D+
Trailing 5 Years  
Capital Gain 32.39% 54% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.39% 54% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.12% 52% F 52% F
Dividend Return 6.12% 51% F 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.24% 35% F 47% F
Risk Adjusted Return 40.16% 42% F 46% F
Market Capitalization 24.16B 99% N/A 91% A-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.